Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways

Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Science, Wenzhou Medical College, Wenzhou, Zhejiang, China.
British Journal of Pharmacology (Impact Factor: 4.84). 01/2012; 166(6):1756-73. DOI: 10.1111/j.1476-5381.2012.01875.x
Source: PubMed


BACKGROUND AND PURPOSE 3-Hydroxy-octanoate, recently identified as a ligand for, the orphan GPCR, HCA(3), is of particular interest given its ability to treat lipid disorders and atherosclerosis. Here we demonstrate the pathway of HCA(3)-mediated activation of ERK1/2. EXPERIMENTAL APPROACH Using CHO-K1 cells stably expressing HCA(3) receptors and A431 cells, a human epidermoid cell line with high levels of endogenous expression of functional HCA(3) receptors, HCA(3)-mediated activation of ERK1/2 was measured by Western blot. KEY RESULTS HCA(3)-mediated activation of ERK1/2 was rapid, peaking at 5 min, and was Pertussis toxin sensitive. Our data, obtained by time course analyses in combination with different kinase inhibitors, demonstrated that on agonist stimulation, HCA(3) receptors evoked ERK1/2 activation via two distinct pathways, the PLC/PKC pathway at early time points (≤ 2 min) and the MMP/ epidermal growth factor receptor (EGFR) transactivation pathway with a maximum response at 5 min. Furthermore, our present results also indicated that the βγ-subunits of the G(i) protein play a critical role in HCA(3)-activated ERK1/2 phosphorylation, whereas β-arrestins and Src were not required for ERK1/2 activation. CONCLUSIONS AND IMPLICATIONS We have described the molecular mechanisms underlying the coupling of human HCA(3) receptors to the ERK1/2 MAP kinase pathway in CHO-K1 and A431 cells, which implicate the G(i) protein-initiated, PLC/PKC -and platelet-derived growth factor receptor/EGFR transactivation-dependent pathways. These observations may provide new insights into the pharmacological effects and the physiological functions modulated by the HCA(3)-mediated activation of ERK1/2.

Download full-text


Available from: Qi Zhou,
  • Source
    • "Phosphorylated ERK immunoblotting using the antibody anti-phospho- ERK1/2 (diluted 1:2000; Cell Signaling Technology) was performed as described previously (Zhou et al., 2012). Total ERK1/2 was detected with anti-ERK1/2 (diluted 1:2000; Cell Signaling Technology). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The human hydroxy-carboxylic acid receptor 2 (HCA(2)), also known as GPR109A and HM74a, was first identified as a niacin receptor and has recently drawn significant attention because of its potential to clinically modify plasma lipids in a favorable manner. Our recent studies have demonstrated that the niacin-induced internalization of HCA(2) receptors is regulated by GRK2 and arrestin3 and that internalized receptors rapidly recycle back to the cell surface. The investigation presented here used a combination of amino acid deletion and site-directed mutagenesis to identify structural and functional domains within the HCA(2) C-terminus and explore their potential roles in receptor phosphorylation, desensitization and internalization. We first constructed four mutants with deletions of 10 to 15 amino acids each that were distinct from truncated mutants. We successfully identified different domains responsible for receptor export, constitutive activity, desensitization, phosphorylation and internalization. We also generated a comprehensive series of alanine substitution mutants, replacing conserved serine and threonine residues in the C-terminus with alanine residues, to pinpoint the key residues that are essential for GRK2-mediated phosphorylation and arrestin3 association. Moreover, we found that a sequence from residues 329 to 343 in the C-terminal tail of HCA(2) plays a crucial role in keeping HCA2 in an inactive conformation. These data demonstrate the importance of distinct domains within the C-terminus of HCA(2) for receptor cell surface expression, desensitization and internalization, phosphorylation and stabilization of an inactive receptor conformation.
    Molecular pharmacology 09/2012; 82(6). DOI:10.1124/mol.112.081307 · 4.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mitogen-activated protein kinase (MAPK) pathways are activated in skeletal muscle during endurance exercise, but the upstream molecular events are incompletely resolved. As an increase in plasma non-esterified fatty acids (NEFA) is a common feature of long-lasting exercise, we tested the hypothesis that NEFA contribute to the activation of MAPK during endurance exercise. Acipimox was used prior and during endurance exercise to prevent the elevation of plasma NEFA levels in healthy subjects and diabetics. In two separate studies, healthy subjects cycled for 2h and diabetics for 1h at 50% Wmax. In control conditions, plasma NEFA concentrations increased from 0.35mM to 0.90mM during exercise in healthy subjects and from 0.55mM to 0.70mM in diabetics (P<0.05). Phosphorylation state of extracellular-regulated kinase 1 and 2 (ERK1/2), p38 and, c-Jun NH2-terminal kinases (JNK) were significantly increased after exercise in the vastus lateralis in both groups. Acipimox blocked the increase in plasma NEFA concentrations and almost completely repressed any rise in ERK1/2 and p38 but not in JNK. In conclusion, our data support a role for plasma NEFA in the activation of p38 and ERK1/2 in skeletal muscle tissue of healthy and diabetic subjects during endurance exercise. Further investigation will be required to determine the molecular link between NEFA and MAPK activation during exercise in human skeletal muscle.
    International Journal of Sport Nutrition and Exercise Metabolism 10/2012; 23(3). · 2.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The gut microbiota affects nutrient acquisition and energy regulation of the host, and can influence the development of obesity, insulin resistance, and diabetes. During feeding, gut microbes produce short-chain fatty acids, which are important energy sources for the host. Here we show that the short-chain fatty acid receptor GPR43 links the metabolic activity of the gut microbiota with host body energy homoeostasis. We demonstrate that GPR43-deficient mice are obese on a normal diet, whereas mice overexpressing GPR43 specifically in adipose tissue remain lean even when fed a high-fat diet. Raised under germ-free conditions or after treatment with antibiotics, both types of mice have a normal phenotype. We further show that short-chain fatty acid-mediated activation of GPR43 suppresses insulin signalling in adipocytes, which inhibits fat accumulation in adipose tissue and promotes the metabolism of unincorporated lipids and glucose in other tissues. These findings establish GPR43 as a sensor for excessive dietary energy, thereby controlling body energy utilization while maintaining metabolic homoeostasis.
    Nature Communications 05/2013; 4:1829. DOI:10.1038/ncomms2852 · 11.47 Impact Factor
Show more